Related Experiment Videos
Risk estimation for fast neutrons with regard to solid cancer
1Radiobiological Institute, University of Munich, Germany. amk.sbi@lrz.uni-muenchen.de
Radiation Research
|December 14, 2001
Summary
Neutron cancer risk assessment can be improved by using epidemiological data instead of low-dose extrapolations. This revised method, applied to A-bomb survivors, suggests neutrons caused a significant portion of radiation-induced cancer mortality.
Area of Science:
- Radiation biology
- Epidemiology
- Dosimetry
Background:
- Current neutron cancer risk assessment relies on low-dose extrapolations.
- This method is considered unnecessary and potentially inaccurate.
Purpose of the Study:
- To propose and apply a new method for deriving neutron cancer mortality risk coefficients.
- To utilize epidemiological data from gamma-ray exposures and neutron relative biological effectiveness (RBE).
Main Methods:
- Derived neutron risk coefficient using excess risk from gamma-ray epidemiological data.
- Applied the method to A-bomb survivor data, considering the neutron dose component (DS86 dosimetry).
- Assessed the impact of varying neutron RBE values (R(1) = 20 or 50).
Main Results:
- Neutrons accounted for 18% or 35% of the total effect at 1 Gy, depending on RBE.
- The excess relative risk (ERR) for neutrons was estimated to be between 8 and 16 per Gy.
- Risk estimates are expected to be robust despite reassessments of neutron doses in Hiroshima.
Conclusions:
- A more direct method for estimating neutron cancer risk is feasible and recommended.
- Neutron radiation contributes significantly to cancer mortality in exposed populations.
- Further analysis is needed to account for the gamma-ray component within neutron fields.